Label: PLASMA-LYTE 148 (PH 7.4)- sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride injection, solution

  • NDC Code(s): 0338-9593-01, 0338-9593-10
  • Packager: Baxter Healthcare Corporation
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Unapproved drug for use in drug shortage

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 8, 2024

If you are a consumer or patient please visit this version.

  • Healthcare Professional Letter

    DHCP Letter 1.jpg
    DHCP Letter 2

    Please refer to the FDA-approved prescribing information for the drug product listed below:
    • Plasma-Lyte A Injection pH 7.4 (click here)

    • Complete and submit the report Online: http://www.fda.gov/medwatch/report.htm
    Regular mail or Fax: Download form http://www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178 (1-800-332-0178).

    To report product quality issues associated with this imported product, please contact Baxter Product Surveillance through Baxter Product Feedback Portal (https://productfeedback.baxter.com/)

    DHCP Letter 3.jpg
    DHCP Letter 4.jpg
    DHCP Letter 5.jpg
    DHCP Letter 6.jpg
  • PACKAGE/LABEL PRINCIPAL DISPLAY PANEL

    PlasmaLyte 1000ml Representative Container Label.jpg

    Container Label

    Baxter

    Viaflo

    GCCE0324

    1000 mL

    100

    200

    300

    400

    500

    600

    700

    800

    900

    Plasma-Lyte 148
    (pH 7.4)

    Solution for Infusion

    pH 6.5 – 8.0
    Isotonic
    Osmolarity 295 m0sm/l (approx)

    Formula per 1000ml
    Sodium Chloride5.26 g
    Potassium Chloride 0.37 g
    Magnesium Chloride hexahydrate 0.30 g
    Sodium Acetate trihydrate3.68 g
    Sodium Gluconate5.02 g
    Water for Injections
    Sodium Hydroxide

    mmol per 100 mL (approx)
    Sodium 140 Chloride 98
    Potassium 5 Acetate 27
    Magnesium 1.5 Gluconate 23

    IV administration
    Read package leaflet before use

    Keep out of the sight and reach of children
    Do not remove from overwrap until ready for use
    Do not use unless solution is clear without visible particles
    and container undamaged
    Do not reconnect partially used bags
    Store below 30oC

    POM
    07
    0

    UN-35-03-560
    1

    Marketing Authorization Holder:
    Baxter Healthcare Ltd.

    Caxton Way
    Thetford Norfolk IP 24 3SE
    United Kingdom

    Manufacturer:
    Bieffe Medital S.A.

    Ctra de Biescas-Senegüé
    22666 Sabiñánigo (Huesca)
    Spain

    LOT

    EXP

  • INGREDIENTS AND APPEARANCE
    PLASMA-LYTE 148 (PH 7.4) 
    sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride injection, solution
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0338-9593
    Route of AdministrationINTRAVENOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SODIUM CHLORIDE (UNII: 451W47IQ8X) (SODIUM CATION - UNII:LYR4M0NH37, CHLORIDE ION - UNII:Q32ZN48698) SODIUM CHLORIDE526 mg  in 100 mL
    SODIUM GLUCONATE (UNII: R6Q3791S76) (GLUCONIC ACID - UNII:R4R8J0Q44B, SODIUM CATION - UNII:LYR4M0NH37) SODIUM GLUCONATE502 mg  in 100 mL
    SODIUM ACETATE (UNII: 4550K0SC9B) (ACETATE ION - UNII:569DQM74SC, SODIUM CATION - UNII:LYR4M0NH37) SODIUM ACETATE368 mg  in 100 mL
    POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152, CHLORIDE ION - UNII:Q32ZN48698) POTASSIUM CHLORIDE37 mg  in 100 mL
    MAGNESIUM CHLORIDE (UNII: 02F3473H9O) (MAGNESIUM CATION - UNII:T6V3LHY838, CHLORIDE ION - UNII:Q32ZN48698) MAGNESIUM CHLORIDE30 mg  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0338-9593-1010 in 1 CARTON11/08/2024
    1NDC:0338-9593-011000 mL in 1 BAG; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug for use in drug shortage11/08/2024
    Labeler - Baxter Healthcare Corporation (005083209)
    Establishment
    NameAddressID/FEIBusiness Operations
    Bieffe Medital SA464755693ANALYSIS(0338-9593) , LABEL(0338-9593) , MANUFACTURE(0338-9593) , PACK(0338-9593) , STERILIZE(0338-9593)